Other
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. > Cell cultures, whether or not modified: > Other > Other > Other
Duty Rate (from China)
Subheadings
Products classified under Tariff item 3002.5
CAR-T Cell Therapy for Leukemia
CAR-T cell therapy consists of patient-derived T-cells that are genetically modified to express chimeric antigen receptors targeting CD19-positive cancer cells. This personalized immunotherapy is used to treat relapsed B-cell acute lymphoblastic leukemia and falls under tariff item 3002.51.00 as a cell therapy product.
3002.51.00Dendritic Cell Vaccine for Prostate Cancer
Dendritic cell vaccine for prostate cancer consists of autologous dendritic cells loaded with tumor-associated antigens and matured ex vivo for personalized cancer vaccination. This product is a cell therapy product under tariff item 3002.51.00, as it involves modified cell cultures for therapeutic use.
3002.51.00iPSC-Derived Cardiomyocyte Therapy for Heart Failure
iPSC-derived cardiomyocyte therapy involves induced pluripotent stem cells differentiated into cardiomyocytes for intramyocardial injection to repair heart tissue after myocardial infarction. These engineered cell cultures are classified under tariff item 3002.51.00 as cell therapy products.
3002.51.00Mesenchymal Stem Cell Therapy for Osteoarthritis
Mesenchymal stem cell therapy for osteoarthritis consists of allogeneic MSCs derived from umbilical cord tissue, expanded and cryopreserved for intra-articular injection. This product is a cell therapy product under tariff item 3002.51.00, as it involves modified cell cultures for therapeutic use.
3002.51.00NK Cell Therapy for Solid Tumors
NK cell therapy for solid tumors involves natural killer cells from peripheral blood that are cytokine-activated and expanded for adoptive transfer in cancer immunotherapy. These modified cell cultures are classified under tariff item 3002.51.00 as cell therapy products.
3002.51.00Treg Cell Therapy for Autoimmune Diseases
Treg cell therapy for autoimmune diseases consists of regulatory T-cells expanded ex vivo from patient blood and modified for enhanced suppressive function, used to treat graft-versus-host disease. This product is a cell therapy product under tariff item 3002.51.00, as it involves modified cell cultures for therapeutic use.
3002.59.00CHO Cell Culture for Protein Expression
Chinese hamster ovary (CHO) cells that have been genetically modified and cultured to produce recombinant therapeutic proteins, such as insulin analogs. These cells are classified as other modified cell cultures for therapeutic uses under tariff item 3002.59.00.
3002.59.00HEK293 Cell Culture
Human embryonic kidney 293 (HEK293) cells cultured for the production of viral vectors used in gene therapy. These cells are classified as other modified cell cultures for therapeutic gene delivery applications under tariff item 3002.59.00.
3002.59.00Human Keratinocyte Cell Culture
Human keratinocyte cell cultures expanded for therapeutic skin graft applications in burn treatment and wound healing. These biotechnologically modified cells are classified as other cell cultures for therapeutic uses under tariff item 3002.59.00.
3002.59.00Human Mesenchymal Stem Cell Culture
Human mesenchymal stem cells cultured in a nutrient medium for regenerative medicine applications, such as treating joint injuries or autoimmune diseases. These cells are classified as other modified cell cultures for therapeutic uses under tariff item 3002.59.00.
3002.59.00Human Neural Progenitor Cell Culture
Human neural progenitor cells expanded in culture for therapies targeting neurodegenerative diseases like Parkinson's. These biotechnologically modified cells are classified as other cell cultures for therapeutic uses under tariff item 3002.59.00.
3002.59.00iPSC-Derived Cardiomyocyte Cell Line
Induced pluripotent stem cell (iPSC)-derived cardiomyocytes grown in specialized media for cardiac repair therapies and drug toxicity testing. These modified cell cultures are classified as other cell cultures for therapeutic uses under tariff item 3002.59.00.
3002.59.00Murine T-Cell Hybridoma Culture
Murine T-cell hybridoma cell lines cultured for producing immunological products like cytokines in cancer immunotherapy. These animal cell cultures are classified as other modified cell cultures for therapeutic uses under tariff item 3002.59.00.
3002.59.00Porcine Islet Cell Culture
Pancreatic islet cells from pigs cultured for xenotransplantation in diabetes treatment. These animal cell cultures are classified as other cell cultures for therapeutic uses under tariff item 3002.59.00.
3002.59.00Primary Human Hepatocyte Cell Culture
Primary human hepatocyte cells freshly isolated from liver tissue and cultured for drug metabolism studies and liver failure therapies. These cell cultures are classified as other cell cultures for therapeutic and diagnostic uses under tariff item 3002.59.00.
3002.59.00Vero Cell Culture for Vaccine Production
Vero cells from African green monkey kidneys cultured as a substrate for growing viruses in vaccine manufacturing. These animal cell cultures are classified as other cell cultures for therapeutic vaccine production uses under tariff item 3002.59.00.